Browsing byAuthorMarsh, DJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 14 to 28 of 28< previous 
Issue DateTitleAuthor(s)
1999-01-01Mutation and deletion analysis of GFRα-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumoursGimm, O; Gössling, A; Marsh, DJ; Dahia, PLM; Mulligan, LM; Von Deimling, A; Eng, C
2014-06-16Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancerChung, L; Moore, K; Phillips, L; Boyle, FM; Marsh, DJ; Baxter, RC
2023-02-18Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma.Pitiyarachchi, O; Lee, YC; Sim, H-W; Srirangan, S; Mapagu, C; Kirk, J; Harnett, PR; Balleine, RL; Bowtell, DDL; Samimi, G; Brand, AH; Marsh, DJ; Beale, P; Anderson, L; Bouantoun, N; Provan, P; INOVATe Investigators,; Ramus, SJ; DeFazio, A; Friedlander, M
2019-01-01Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) parathyroid tumors demonstrate distinctive morphologic featuresGill, AJ; Lim, G; Cheung, VKY; Andrici, J; Perry-Keene, JL; Paik, J; Sioson, L; Clarkson, A; Sheen, A; Luxford, C; Elston, MS; Meyer-Rochow, GY; Nano, MT; Kruijff, S; Engelsman, AF; Sywak, M; Sidhu, SB; Delbridge, LW; Robinson, BG; Marsh, DJ; Toon, CW; Chou, A; Clifton-Bligh, RJ
-PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian CancerDickson, K-A; Xie, T; Evenhuis, C; Ma, Y; Marsh, DJ
2023-10-12PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics.Travis, G; McGowan, EM; Simpson, AM; Marsh, DJ; Nassif, NT
2021-01Studying the Oncosuppressive Functions of PTENP1 as a ceRNA.Travis, G; Haddadi, N; Simpson, AM; Marsh, DJ; McGowan, EM; Nassif, NT
2022-09-23Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall SurvivalXie, T; Dickson, K-A; Yee, C; Ma, Y; Ford, CE; Bowden, NA; Marsh, DJ
2022-04-11The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer CellsLiu, D; Kaufmann, GF; Breitmeyer, JB; Dickson, K-A; Marsh, DJ; Ford, CE
2016-12-15The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancerDickson, K-A; Cole, AJ; Gill, AJ; Clarkson, A; Gard, GB; Chou, A; Kennedy, CJ; Henderson, BR; Fereday, S; Traficante, N; Alsop, K; Bowtell, DD; deFazio, A; Clifton-Bligh, R; Marsh, DJ
2022-02-10Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized MedicineYee, C; Dickson, K-A; Muntasir, MN; Ma, Y; Marsh, DJ
2013-02-01Tissue biomarkers of breast cancer and their association with conventional pathologic featuresChung, L; Shibli, S; Moore, K; Elder, EE; Boyle, FM; Marsh, DJ; Baxter, RC
2019-10-15Toward Systems Pathology for PTEN Diagnostics.Haddadi, N; Travis, G; Nassif, NT; Simpson, AM; Marsh, DJ
2020-05-26Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways.Cole, AJ; Dickson, K-A; Liddle, C; Stirzaker, C; Shah, JS; Clifton-Bligh, R; Marsh, DJ
2019-01-01Writing histone monoubiquitination in human malignancy—The role of RING finger E3 ubiquitin ligasesMarsh, DJ; Dickson, KA